SPRR2A and neoplasm: Wang P. et al. (2017) constructed an OAd (Ad-TD-nsIL-12) with triple gene deletions (E1ACR2, E1B19K, and E3gp19K) to deliver non-secreting IL-12 (nsIL-12) into tumor cells.